Suivre
Lukas Martin
Lukas Martin
Medical Doctor, Priv.-Doz. Dr. med., MHBA
Adresse e-mail validée de ukaachen.de
Titre
Citée par
Citée par
Année
The septic heart: current understanding of molecular mechanisms and clinical implications
L Martin, M Derwall, S Al Zoubi, E Zechendorf, DA Reuter, ...
Chest 155 (2), 427-437, 2019
2522019
The endothelial glycocalyx: new diagnostic and therapeutic approaches in sepsis
L Martin, P Koczera, E Zechendorf, T Schuerholz
BioMed research international 2016, 2016
1502016
The ribonuclease a superfamily in humans: canonical RNases as the buttress of innate immunity
P Koczera, L Martin, G Marx, T Schuerholz
International journal of molecular sciences 17 (8), 1278, 2016
1322016
Antimicrobial peptides in human sepsis
L Martin, A Van Meegern, S Doemming, T Schuerholz
Frontiers in immunology 6, 404, 2015
1312015
Telemedicine in Germany during the COVID-19 pandemic: multi-professional national survey
A Peine, P Paffenholz, L Martin, S Dohmen, G Marx, SH Loosen
Journal of medical Internet research 22 (8), e19745, 2020
1182020
The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies
M Derwall, L Martin, R Rossaint
Expert Review of Respiratory Medicine 12 (12), 1021-1029, 2018
742018
Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey
P Paffenholz, A Peine, M Hellmich, SV Paffenholz, L Martin, M Luedde, ...
Emerging microbes & infections 9 (1), 1590-1599, 2020
672020
Development and validation of a reinforcement learning algorithm to dynamically optimize mechanical ventilation in critical care
A Peine, A Hallawa, J Bickenbach, G Dartmann, LB Fazlic, A Schmeink, ...
NPJ digital medicine 4 (1), 32, 2021
652021
The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study
T Schuerholz, S Doemming, M Hornef, L Martin, TP Simon, L Heinbockel, ...
Critical Care 17, 1-9, 2013
582013
The synthetic antimicrobial peptide 19-2.5 interacts with heparanase and heparan sulfate in murine and human sepsis
L Martin, R De Santis, P Koczera, N Simons, H Haase, L Heinbockel, ...
PloS one 10 (11), e0143583, 2015
562015
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
GSD Purvis, F Chiazza, J Chen, R Azevedo-Loiola, L Martin, ...
Diabetologia 61, 482-495, 2018
522018
Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum
L Martin, S Schmitz, R De Santis, S Doemming, H Haase, J Hoeger, ...
PloS one 10 (5), e0127584, 2015
502015
Soluble heparan sulfate in serum of septic shock patients induces mitochondrial dysfunction in murine cardiomyocytes
L Martin, C Peters, S Schmitz, J Moellmann, A Martincuks, N Heussen, ...
Shock 44 (6), 569-577, 2015
492015
Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsis
E Zechendorf, CE O’Riordan, L Stiehler, N Wischmeyer, F Chiazza, ...
JCI insight 5 (8), 2020
412020
Heart in sepsis: molecular mechanisms, diagnosis and therapy of septic cardiomyopathy
L Martin, M Derwall, C Thiemermann, T Schürholz
Der Anaesthesist 66, 479-490, 2017
392017
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis
L Martin, K Horst, F Chiazza, S Oggero, M Collino, K Brandenburg, ...
Scientific reports 6 (1), 37277, 2016
382016
Linagliptin attenuates the cardiac dysfunction associated with experimental sepsis in mice with pre-existing type 2 diabetes by inhibiting NF-κB
S Al Zoubi, J Chen, C Murphy, L Martin, F Chiazza, D Collotta, ...
Frontiers in immunology 9, 423123, 2018
362018
Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
CE O'Riordan, GSD Purvis, D Collotta, F Chiazza, B Wissuwa, S Al Zoubi, ...
Frontiers in Immunology 10, 465227, 2019
352019
Plasma adrenomedullin in critically ill patients with sepsis after major surgery: a pilot study
TP Simon, L Martin, S Doemming, A Humbs, C Bruells, R Kopp, ...
Journal of critical care 38, 68-72, 2017
302017
RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance
J Chen, GSD Purvis, D Collotta, S Al Zoubi, MA Sugimoto, A Cacace, ...
Frontiers in immunology 11, 2080, 2020
272020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20